Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ensio Norjavaara

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Hormone Research in Paediatrics|March 25, 2016
First Morning Voided Urinary Gonadotropin Measurements as an Alternative to the GnRH TestAnd Demir, Raimo Voutilainen, Ulf-Håkan Stenman, et al.
The Journal of Allergy and Clinical Immunology|January 18, 2003
Is there an association between inhaled corticosteroids and bone density in postmenopausal women?Sölve Elmståhl, Henrik Ekström, Herbert Galvard, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 1, 2006
Pubertal timing predicts previous fractures and BMD in young adult men: the GOOD studyJenny M Kindblom, Mattias Lorentzon, Ensio Norjavaara, et al.
The Journal of Clinical Endocrinology and Metabolism|June 23, 2012
Glucokinase activators AZD6370 and AZD1656 do not affect the central counterregulatory response to hypoglycemia in healthy malesEnsio Norjavaara, Hans Ericsson, Folke Sjöberg, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 5, 2012
Tolerability, pharmacokinetics, and pharmacodynamics of the glucokinase activator AZD1656, after single ascending doses in healthy subjects during euglycemic clampHans Ericsson, Daniel Röshammar, Maria Wollbratt, et al.
Diabetes|January 27, 2009
BMI changes during childhood and adolescence as predictors of amount of adult subcutaneous and visceral adipose tissue in men: the GOOD StudyJenny M Kindblom, Mattias Lorentzon, Asa Hellqvist, et al.
The Lancet. Diabetes & Endocrinology|April 4, 2022
Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 studyWilliam V Tamborlane, Lori M Laffel, Naim Shehadeh, et al.
Diabetes|October 27, 2006
Pubertal timing is an independent predictor of central adiposity in young adult males: the Gothenburg osteoporosis and obesity determinants studyJenny M Kindblom, Mattias Lorentzon, Ensio Norjavaara, et al.
Toxicology and Applied Pharmacology|May 6, 2008
PPARalpha regulates the hepatotoxic biomarker alanine aminotransferase (ALT1) gene expression in human hepatocytesPetra Thulin, Ingalill Rafter, Kenneth Stockling, et al.
Therapeutic Innovation & Regulatory Science|February 8, 2020
How is the Pharmaceutical Industry Structured to Optimize Pediatric Drug Development? Existing Pediatric Structure Models and Proposed Recommendations for Structural EnhancementThomas Severin, Solange Corriol-Rohou, Christina Bucci-Rechtweg, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Hormone Research in Paediatrics|March 25, 2016
First Morning Voided Urinary Gonadotropin Measurements as an Alternative to the GnRH TestAnd Demir, Raimo Voutilainen, Ulf-Håkan Stenman, et al.
The Journal of Allergy and Clinical Immunology|January 18, 2003
Is there an association between inhaled corticosteroids and bone density in postmenopausal women?Sölve Elmståhl, Henrik Ekström, Herbert Galvard, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 1, 2006
Pubertal timing predicts previous fractures and BMD in young adult men: the GOOD studyJenny M Kindblom, Mattias Lorentzon, Ensio Norjavaara, et al.
The Journal of Clinical Endocrinology and Metabolism|June 23, 2012
Glucokinase activators AZD6370 and AZD1656 do not affect the central counterregulatory response to hypoglycemia in healthy malesEnsio Norjavaara, Hans Ericsson, Folke Sjöberg, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 5, 2012
Tolerability, pharmacokinetics, and pharmacodynamics of the glucokinase activator AZD1656, after single ascending doses in healthy subjects during euglycemic clampHans Ericsson, Daniel Röshammar, Maria Wollbratt, et al.
Diabetes|January 27, 2009
BMI changes during childhood and adolescence as predictors of amount of adult subcutaneous and visceral adipose tissue in men: the GOOD StudyJenny M Kindblom, Mattias Lorentzon, Asa Hellqvist, et al.
The Lancet. Diabetes & Endocrinology|April 4, 2022
Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 studyWilliam V Tamborlane, Lori M Laffel, Naim Shehadeh, et al.
Diabetes|October 27, 2006
Pubertal timing is an independent predictor of central adiposity in young adult males: the Gothenburg osteoporosis and obesity determinants studyJenny M Kindblom, Mattias Lorentzon, Ensio Norjavaara, et al.
Toxicology and Applied Pharmacology|May 6, 2008
PPARalpha regulates the hepatotoxic biomarker alanine aminotransferase (ALT1) gene expression in human hepatocytesPetra Thulin, Ingalill Rafter, Kenneth Stockling, et al.
Therapeutic Innovation & Regulatory Science|February 8, 2020
How is the Pharmaceutical Industry Structured to Optimize Pediatric Drug Development? Existing Pediatric Structure Models and Proposed Recommendations for Structural EnhancementThomas Severin, Solange Corriol-Rohou, Christina Bucci-Rechtweg, et al.
Pageof 5